OREX
Orexigen Therapeutics, Inc.
OREX
OREX
Delisted
OREX was delisted on the 3rd of April, 2018.
128 hedge funds and large institutions have $431M invested in Orexigen Therapeutics, Inc. in 2014 Q3 according to their latest regulatory filings, with 21 funds opening new positions, 52 increasing their positions, 30 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
19% less call options, than puts
Call options by funds: $8.43M | Put options by funds: $10.4M
26% less capital invested
Capital invested by funds: $579M → $431M (-$148M)
Holders
128
Holding in Top 10
1
Calls
$8.43M
Puts
$10.4M
Top Buyers
| 1 | +$14.3M | |
| 2 | +$9.79M | |
| 3 | +$7.56M | |
| 4 |
Morgan Stanley
New York
|
+$4.97M |
| 5 |
CC
CQS Cayman
Camana Bay, Grand Cayman,
Cayman Islands
|
+$4.64M |
Top Sellers
| 1 | -$11.8M | |
| 2 | -$7.51M | |
| 3 | -$5.7M | |
| 4 |
Fidelity International
Hamilton,
Bermuda
|
-$5.01M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$2.87M |